Embody vs Start Willow: Price, Shipping, and Compounded Options

Quick comparison: Embody vs Start Willow

Short verdict: Embody is the lower-cost, no-frills option with compounded semaglutide from $69/month and 1–2 day free shipping after approval; Start Willow costs from $249/month (rising to $299 ongoing) and emphasizes personalized clinician collaboration with delivery in 3 days or less.

See Embody pricing and options

How these programs differ at a glance

This comparison focuses on five clear, supported differences: price and pricing model, shipping speed, medication positioning and regulatory notes, personalization and features, and who each provider is best for. Every claim below is stated using the source language and qualifiers provided.

Price and pricing model

Embody: Compounded semaglutide is offered at $69/month (noted as cut from $299), with compounded tirzepatide at $119/month. Embody markets flat locked-in monthly pricing, no monthly membership, and cancel anytime. Start Willow: Priced from $249 for the first month and $299/month ongoing; no membership fees but the ongoing $299/month is described as higher than many alternatives.

Start Embody at $69/month

Shipping and delivery

Embody advertises free shipping with delivery in 1–2 days after clinician approval. Start Willow guarantees delivery in 3 days or less and lists same day prescriptions with free 2-day shipping in other captured material. Both providers describe fast delivery windows from licensed pharmacies; Embody emphasizes 1–2 day arrival while Start Willow emphasizes a 3-day or less guarantee.

Medication type, branding, and regulatory notes

Both providers offer compounded semaglutide and state their compounded medications are not FDA-approved finished products. Embody explicitly notes its offerings are compounded semaglutide and compounded tirzepatide and repeats that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Start Willow describes medications comparable to branded Ozempic and tirzepatide but likewise states that compounded semaglutide is not FDA-approved and that compounding pharmacies operate under state board oversight and USP standards.

Personalization, clinical review, and platform features

Start Willow positions its semaglutide as a customized treatment “designed in collaboration with your Willow doctor as part of your individualized care plan,” highlighting personalization for patients with specific health profiles or treatment goals. Embody emphasizes a prescription and telemed visit model, licensed provider review handled entirely online, and 24/7 support access for dosing and side-effect questions, but notes it has fewer premium features such as integrated coaching or advanced monitoring compared with higher-priced platforms.

Direct comparison table

Safety and regulatory language

Both sources explicitly state that their compounded medications are not FDA-approved finished products and that the FDA does not review compounded medications for safety, effectiveness, or quality. Start Willow adds that compounded medications are prepared by state-licensed compounding pharmacies operating under state board oversight and USP compounding standards.

Patient experience and trade-offs

Embody markets itself as “best for cost-driven patients” who want a straightforward program without premium add-ons, highlighting low entry price and fast 1–2 day shipping. Start Willow is described as best for patients frustrated by insurance pre-authorization, offering a direct-pay model and clinician collaboration, but with ongoing pricing that may be higher than many alternatives.

See Start Willow plans and timeline

Bottom line and who should choose which

Embody vs Start Willow comes down to cost and personalization. Embody delivers the lowest entry price and the fastest advertised shipping window, while Start Willow emphasizes clinician collaboration, a tailored plan, and a delivery guarantee but at a higher ongoing cost.

Review Start Willow’s clinician-guided options

Compare Embody’s low-cost offerings

Choose Embody if…

You prioritize the lowest possible monthly entry price for compounded semaglutide or tirzepatide, want free 1–2 day shipping after approval, prefer a simple telehealth prescription model with no membership, and accept that medications are compounded and not FDA-approved finished products.

Choose Start Willow if…

You value a personalized, clinician-collaborative treatment plan and want a provider that emphasizes tailored medication design and a 3-day delivery guarantee, and you accept a higher ongoing cost that starts from $249 and typically moves to $299/month.